mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.1 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |